Type 2 Diabetes Mellitus and Hyperlipidemia
Conditions
Interventions
Trial group:Sanye Tablets + Acarbose Simulation Agent
The placebo group:Sanye Tablets Simulation Agent + Acarbose Simulation Agent
Positive medicine control group:Acarbose +Sanye Tablets Simulation Agent
Sponsors
Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients with Type 2 Diabetes (FGB 7.0-10.0mmol/L, 7%=2.26 mmo1/L; 4. Aged 18 to 75 years old; 5. Before and after 2 weeks period of check: FGB, TG are less than 15%; 6. Voluntarily signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Have Diabetes Ketosis, Ketoacidosis, Severe Infection and Trauma, Major Surgery nearly a month; 2. Accompanied by Liver and Kidney Dysfunction (AST, ALT>1.5 times normal cap, Serum Creatinine>upper limit of normal), Lung Dysfunction, Heart Failure, severe primary diseases such as Acute Myocardial Infarction; 3. With severe chronic diabetes complications (such as Diabetic Nephropathy, Diabetic Fundus Lesions); 4. Pregnancy, ready for pregnancy or lactation; 5. Our Chinese native medicine ingredient in drug allergy; 6. Psychiatric patients; 7. In other clinical trials of patients for nearly three months; 8. The use of Heparin, Thyroxine and other drugs affect blood lipid metabolism of patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbAlc; | — |
Secondary
| Measure | Time frame |
|---|---|
| FBG;TC;TG;HDL-C;LDL-C;FINS;FGly;OGTT2hPG;EPC;CEC;OGTT2hGly; | — |
Countries
China
Contacts
Public ContactHUANG Yuhong
Outcome results
None listed